{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:39:04Z","timestamp":1760369944585},"reference-count":20,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej23-0330","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T22:36:24Z","timestamp":1696026984000},"page":"999-1003","source":"Crossref","is-referenced-by-count":1,"title":["Adjuvant treatments for locally advanced differentiated thyroid cancer: a nationwide survey in Japan"],"prefix":"10.1507","volume":"70","author":[{"given":"Terufumi","family":"Kawamoto","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Juntendo University, Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Showa University School of Medicine, Tokyo 142-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadamoto","family":"Zenda","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center Hospital East, Chiba 277-8577, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Sakanaka","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Shikama","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Juntendo University, Graduate School of Medicine, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, St.Marianna University School of Medicine Hospital, Kanagawa 216-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mizowaki","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013: 965212.","DOI":"10.1155\/2013\/965212"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26: 1\u2013133.","DOI":"10.1089\/thy.2015.0020"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Ito Y, Onoda N, Okamoto T (2020) The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: core questions and recommendations for treatments of thyroid cancer. Endocr J 67: 669\u2013717.","DOI":"10.1507\/endocrj.EJ20-0025"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Brierley J, Tsang R, Panzarella T, Bana N (2005) Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 63: 418\u2013427.","DOI":"10.1111\/j.1365-2265.2005.02358.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Chow SM, Yau S, Kwan CK, Poon PC, Law SC (2006) Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Endocr Relat Cancer 13: 1159\u20131172.","DOI":"10.1677\/erc.1.01320"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Keum KC, Suh YG, Koom WS, Cho JH, Shim SJ, et al. (2006) The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea. Int J Radiat Oncol Biol Phys 65: 474\u2013480.","DOI":"10.1016\/j.ijrobp.2005.12.010"},{"key":"7","unstructured":"7 Chen PV, Osborne R, Ahn E, Avitia S, Juillard G (2009) Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer. Ear Nose Throat J 88: E01."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, et al. (2009) Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys 74: 1083\u20131091.","DOI":"10.1016\/j.ijrobp.2008.09.023"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Lee EK, Lee YJ, Jung YS, Ryu J, Kim TH, et al. (2015) Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis. J Clin Endocrinol Metab 100: 1009\u20131017.","DOI":"10.1210\/jc.2014-3242"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Lee NK, Kim CY, Baek SK, Jung KY (2016) The role of adjuvant radiation therapy for locoregionally advanced papillary thyroid carcinoma. Oncology 90: 209\u2013214.","DOI":"10.1159\/000444393"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kim YS, Choi JH, Kim KS, Lim GC, Kim JH, et al. (2017) The role of adjuvant external beam radiation therapy for papillary thyroid carcinoma invading the trachea. Radiat Oncol J 35: 112\u2013120.","DOI":"10.3857\/roj.2017.00192"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tam S, Amit M, Boonsripitayanon M, Cabanillas ME, Busaidy NL, et al. (2017) Adjuvant external beam radiotherapy in locally advanced differentiated thyroid cancer. JAMA Otolaryngol Head Neck Surg 143: 1244\u20131251.","DOI":"10.1001\/jamaoto.2017.2077"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13 Kawamoto T, Shikama N, Fukumori T, Hoshi M, Yamada T (2023) Propensity score matching analysis of adjuvant external-beam radiotherapy for the treatment of papillary thyroid carcinoma with other organ invasions. Endocrine 80: 589\u2013599.","DOI":"10.1007\/s12020-023-03300-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Sit D, Koh WX, Shokoohi A, Raycraft T, Vu M, et al. (2021) External beam radiation therapy in pt4 well-differentiated thyroid cancer: a population-based study of 405 patients. Int J Radiat Oncol Biol Phys 111: 468\u2013478.","DOI":"10.1016\/j.ijrobp.2021.05.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Shindo ML, Caruana SM, Kandil E, McCaffrey JC, Orloff LA, et al. (2014) Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement. Head Neck 36: 1379\u20131390.","DOI":"10.1002\/hed.23619"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kawamoto T, Shikama N, Fukumori T, Hoshi M, Yamada T (2023) Long-term clinical outcomes and prognostic factors for patients with papillary thyroid carcinoma with other organ invasions after adjuvant radioactive iodine. Endocrine 80: 79\u201385.","DOI":"10.1007\/s12020-022-03251-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Lamartina L, Ippolito S, Danis M, Bidault F, Borget I, et al. (2016) Antiangiogenic tyrosine kinase inhibitors: occurrence and risk factors of hemoptysis in refractory thyroid cancer. J Clin Endocrinol Metab 101: 2733\u20132741.","DOI":"10.1210\/jc.2015-4391"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Hedman C, Dj\u00e4rv T, Strang P, Lundgren CI (2016) Determinants of long-term quality of life in patients with differentiated thyroid carcinoma - a population-based cohort study in Sweden. Acta Oncol 55: 365\u2013369.","DOI":"10.3109\/0284186X.2015.1102965"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Romesser PB, Sherman EJ, Whiting K, Ho ML, Shaha AR, et al. (2021) Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: a prospective phase 2 trial. Cancer 127: 4161\u20134170.","DOI":"10.1002\/cncr.33804"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 International Commission on Radiological Protection (2004) Release of patients after therapy with unsealed radionuclides. Ann ICRP 34: v\u2013vi, 1\u201379.","DOI":"10.1016\/j.icrp.2004.08.001"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/10\/70_EJ23-0330\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T04:16:09Z","timestamp":1699071369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/10\/70_EJ23-0330\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej23-0330","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ23-0330"}}